Results 241 to 250 of about 367,294 (339)
Association of Vitamin D Deficiency with Diabetic Nephropathy in Type 2 Diabetes: A Hospital-Based Cross-Sectional Study. [PDF]
DiseasesBashir S +9 more
europepmc +1 more source
Diabetic nephropathy and proximal tubule ROS: Challenging our glomerulocentricity [PDF]
, 2007 Susan P. Bagby
openalex +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aim Type 2 diabetes (T2D) is associated with increased dementia risk, but comparative data across newer glucose‐lowering therapies remain limited. We examined whether the initiation of GLP‐1 receptor agonists (GLP‐1 RAs) was associated with incident dementia compared with DPP4 inhibitors (DPP4is) and SGLT2 inhibitors (SGLT2is) in older adults ...
Ting Zhou +9 more
wiley +1 more source
Acute hepatitis E virus infection as a trigger for postinfectious IgA nephropathy: A rare case report. [PDF]
Medicine (Baltimore)Khan M +6 more
europepmc +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Introduction Diabetic kidney disease (DKD) and diabetic nephropathy (DN) affect around 40% of diabetic patients but lack accurate risk prediction tools that include social determinants and demographic complexity. We developed and validated an ensemble machine learning model for three‐year DKD/DN risk prediction with deployment readiness ...
Ayla M. Tourkmani +5 more
wiley +1 more source
Case report: A rare case of IgA nephropathy associated with type II Abernethy malformation. [PDF]
Front Med (Lausanne)Cao W, Guo X, Zhao X, Gao Y.
europepmc +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims The risk of diabetic nephropathy among patients with type 2 diabetes (T2D) can be reduced through optimal glycaemic control. It is not known if the pharmacological properties of long‐acting insulin analogues may reduce the risk of diabetic complications compared with neutral protamine Hagedorn (NPH) insulin.
Julia Brillinger +6 more
wiley +1 more source
Acute kidney injury after treatment with arsenic trioxide. [PDF]
Clin Nephrol Case StudNajar H +4 more
europepmc +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims The extent to which the cardiovascular benefits of sodium–glucose co‐transporter 2 inhibitors (SGLT‐2is) and glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) differ by sex remains unclear. This systematic meta‐analysis aimed to investigate sex differences in trial representation and the cardiovascular and kidney efficacy of SGLT‐2is ...
Magdaline Zawadka +6 more
wiley +1 more source